UK markets closed
  • FTSE 100

    +59.28 (+0.85%)
  • FTSE 250

    +206.11 (+0.91%)
  • AIM

    +4.45 (+0.36%)

    -0.0013 (-0.11%)

    -0.0013 (-0.10%)

    +583.32 (+2.37%)
  • CMC Crypto 200

    -7.40 (-0.93%)
  • S&P 500

    +44.31 (+1.01%)
  • DOW

    +238.20 (+0.68%)

    +0.26 (+0.36%)

    -3.30 (-0.18%)
  • NIKKEI 225

    +159.80 (+0.58%)

    -401.86 (-1.45%)
  • DAX

    +154.75 (+1.00%)
  • CAC 40

    +87.23 (+1.35%)

Insights on the Gene Expression Analysis Global Market to 2026 - by Products & Services, Technology, Capacity, End-user and Region

·9-min read

Dublin, July 15, 2021 (GLOBE NEWSWIRE) -- The "Gene Expression Analysis Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to's offering.

The global gene expression analysis market exhibited strong growth during 2015-2020. Gene expression analysis (GEA) is the method of extracting data from a gene to investigate the behaviour of biological systems. It involves different processes such as gene transcription, translation, post-translational modification of protein and RNA splicing. The data obtained from this analysis is used for the production of proteins, Ribonucleic Acid (RNA) and various microbiological products. They are further utilized for the development of new drugs and improving the existing diagnostic methods. GEA is now widely considered to be essential in explaining the mechanisms that cause numerous medical ailments, owing to which it finds extensive applications in pharmacogenomics, biomarking, toxicology and diagnostics.

The increasing adoption of targeted molecular therapeutics, along with the growing demand for personalized medicines, is among the key factors driving the growth of the market. GEA has proven to be a powerful tool in molecular biology studies, which are used to understand the functioning of genes, diagnose ailments and facilitate drug development. Furthermore, the growing prevalence of chronic diseases, such as cancer, tuberculosis, and cardiovascular and genetic disorders is providing a significant boost to the market growth.

Additionally, the development of personalized medicines to cure these ailments has enabled the modifications of diagnostic and treatment methods according to the individual patient requirement. Moreover, various technological advancements, such as the advent of Next Generation Sequencing (NGS), along with the development of genomic databases, higher success rates of GEA and enhanced focus on research and development (R&D) in gene therapy, are further projected to drive the market growth. Looking forward, the publisher expects the global gene expression analysis market to grow at a CAGR of around 10% during 2021-2026.

Breakup by Products & Services:

  • Consumables

  • Instruments

  • Services

Breakup by Technology:

  • Polymerase Chain Reaction (PCR)

  • Next Generation Sequencing (NGS)

  • DNA Microarray

  • Sanger Sequencing

  • Others

Breakup by Capacity:

  • Low-to Mid-Plex Gene Expression Analysis

  • High-Plex Gene Expression Analysis

Breakup by End-User:

  • Pharmaceutical and Biotech Companies

  • Academic Institutes and Research Centers

  • Others

Breakup by Region:

  • North America

  • United States

  • Canada

  • Europe

  • Germany

  • France

  • United Kingdom

  • Italy

  • Spain

  • Russia

  • Asia Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia

  • Indonesia

  • Latin America

  • Brazil

  • Mexico

  • Argentina

  • Columbia

  • Chile

  • Peru

  • Middle East and Africa

  • Turkey

  • Saudi Arabia

  • Iran

  • United Arab Emirates

  • Others

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Agilent Technologies, BGI, Bio-Rad Laboratories Inc., Eurofins Scientific, F. Hoffmann-La Roche, GE Healthcare, Illumina, Inc., Oxford Gene Technology, Pacific Biosciences of California Inc., Perkinelmer Inc., Qiagen N.V., Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global gene expression analysis market performed so far and how will it perform in the coming years?

  • What are the key regional markets?

  • What has been the impact of COVID-19 on the global gene expression analysis market?

  • What is the breakup of the market based on the products & services?

  • What is the breakup of the market based on the technology?

  • What is the breakup of the market based on the capacity?

  • What is the breakup of the market based on the end-user?

  • What are the various stages in the value chain of the industry?

  • What are the key driving factors and challenges in the market?

  • What is the structure of the global gene expression analysis market and who are the key players?

  • What is the degree of competition in the market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Gene Expression Analysis Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact Of COVID-19
5.4 Market Forecast

6 Market Breakup by Products & Services
6.1 Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Instruments
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Services
6.3.1 Market Trends
6.3.2 Market Forecast

7 Market Breakup by Technology
7.1 Polymerase Chain Reaction (PCR)
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Next Generation Sequencing (NGS)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 DNA Microarray
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Sanger Sequencing
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast

8 Market Breakup by Capacity
8.1 Low-to Mid-Plex Gene Expression Analysis
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 High-Plex Gene Expression Analysis
8.2.1 Market Trends
8.2.2 Market Forecast

9 Market Breakup by End-User
9.1 Pharmaceutical and Biotech companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic Institutes and Research Centers
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market Trends
9.3.2 Market Forecast

10 Market Breakup by Region
10.1 North America
10.1.1 United States Market Trends Market Forecast
10.1.2 Canada Market Trends Market Forecast
10.2 Europe
10.2.1 Germany Market Trends Market Forecast
10.2.2 France Market Trends Market Forecast
10.2.3 United Kingdom Market Trends Market Forecast
10.2.4 Italy Market Trends Market Forecast
10.2.5 Spain Market Trends Market Forecast
10.2.6 Russia Market Trends Market Forecast
10.2.7 Others Market Trends Market Forecast
10.3 Asia-Pacific
10.3.1 China Market Trends Market Forecast
10.3.2 Japan Market Trends Market Forecast
10.3.3 India Market Trends Market Forecast
10.3.4 South Korea Market Trends Market Forecast
10.3.5 Australia Market Trends Market Forecast
10.3.6 Indonesia Market Trends Market Forecast
10.3.7 Others Market Trends Market Forecast
10.4 Latin America
10.4.1 Brazil Market Trends Market Forecast
10.4.2 Mexico Market Trends Market Forecast
10.4.3 Argentina Market Trends Market Forecast
10.4.4 Columbia Market Trends Market Forecast
10.4.5 Chile Market Trends Market Forecast
10.4.6 Peru Market Trends Market Forecast
10.4.7 Others Market Trends Market Forecast
10.5 Middle East and Africa
10.5.1 Turkey Market Trends Market Forecast
10.5.2 Saudi Arabia Market Trends Market Forecast
10.5.3 Iran Market Trends Market Forecast
10.5.4 United Arab Emirates Market Trends Market Forecast
10.5.5 Others Market Trends Market Forecast

11 SWOT Analysis

12 Value Chain Analysis

13 Porters Five Forces Analysis

14 Price Indicators

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Agilent Technologies Company Overview Product Portfolio Financials SWOT Analysis
15.3.2 BGI Company Overview Product Portfolio
15.3.3 Bio-Rad Laboratories Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.4 Eurofins Scientific Company Overview Product Portfolio
15.3.5 F. Hoffmann-La Roche Company Overview Product Portfolio Financials
15.3.6 GE Healthcare Company Overview Product Portfolio
15.3.7 Illumina Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.8 Oxford Gene Technology Company Overview Product Portfolio Financials
15.3.9 Pacific Biosciences of California Inc. Company Overview Product Portfolio Financials
15.3.10 Perkinelmer Inc. Company Overview Product Portfolio Financials SWOT Analysis
15.3.11 Qiagen N.V. Company Overview Product Portfolio Financials
15.3.12 Thermo Fisher Scientific Inc. Company Overview Product Portfolio Financials SWOT Analysis

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting